EGFR and cancer: The most recurrent genetic alterations in non-small cell lung cancer (NSCLC, 85% of lung cancers) consist of mutations in the epidermal growth factor receptor (EGFR) gene, leading to uncontrolled cellular proliferation, inhibition of apoptosis and thus, tissue growth and cancer.